Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results

Go back to Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results
GALMED PHARMACEUTIC (NASDAQ: GLMD) Delayed: 4.63 --0 (-0%)
Previous Close $4.63    52 Week High $9.70 
Open $4.63    52 Week Low $2.78 
Day High $4.63    P/E N/A 
Day Low $4.63    EPS $0.00 
Volume 2,258,829